Description:

Lung infections caused by viruses, such as flu and RSV, are common. But in some cases they can lead to severe illness that can require hospitalisation and intensive care admission. Ioannis and AnnaMaria share their views on the impact of these infections and how we are using our expertise in respiratory and inflammatory disease to explore new treatments to manage the effects of severe viral lung infections by targeting IL33 a key driver of inflammation.

Follow the science further on our website: https://www.astrazeneca.com/whatscie...


Global site: https://www.astrazeneca.com/
Careers site: https://careers.astrazeneca.com/

Follow us:
Twitter:   / astrazeneca  
LinkedIn:   / astrazeneca  
Instagram:   / astrazeneca  
Facebook:   / astrazeneca